Insider Transactions in Q1 2024 at Atara Biotherapeutics, Inc. (ATRA)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 31
2024
|
Ameet Mallik |
BUY
Grant, award, or other acquisition
|
Direct |
150,000
+39.74%
|
-
|
|
Mar 31
2024
|
Carol Giltner Gallagher |
BUY
Grant, award, or other acquisition
|
Direct |
150,000
+19.24%
|
-
|
|
Mar 31
2024
|
Maria Grazia Roncarolo |
BUY
Grant, award, or other acquisition
|
Direct |
150,000
+38.61%
|
-
|
|
Mar 31
2024
|
William K Heiden |
BUY
Grant, award, or other acquisition
|
Direct |
150,000
+29.47%
|
-
|
|
Mar 31
2024
|
Matthew K Fust |
BUY
Grant, award, or other acquisition
|
Direct |
150,000
+36.67%
|
-
|
|
Mar 04
2024
|
Amar Murugan EVP, Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
10,044
-1.36%
|
$0
$0.72 P/Share
|
|
Mar 04
2024
|
Anh Co Nguyen President and CEO |
SELL
Open market or private sale
|
Direct |
10,746
-1.13%
|
$0
$0.72 P/Share
|
|
Mar 04
2024
|
Pascal Touchon President and CEO |
SELL
Open market or private sale
|
Direct |
24,844
-1.28%
|
$0
$0.72 P/Share
|
|
Mar 04
2024
|
Jill Henrich EVP, Global Head RA & Quality |
SELL
Open market or private sale
|
Direct |
3,879
-0.69%
|
$0
$0.72 P/Share
|
|
Mar 04
2024
|
Eric J Hyllengren EVP, CFO |
SELL
Open market or private sale
|
Direct |
6,679
-0.49%
|
$0
$0.72 P/Share
|
|
Jan 08
2024
|
Jill Henrich EVP, Global Head RA & Quality |
BUY
Grant, award, or other acquisition
|
Direct |
450,000
+44.6%
|
-
|
|
Jan 08
2024
|
Eric J Hyllengren EVP, CFO |
BUY
Grant, award, or other acquisition
|
Direct |
475,000
+41.09%
|
-
|
|
Jan 08
2024
|
Amar Murugan EVP, Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
475,000
+39.17%
|
-
|
|
Jan 08
2024
|
Anh Co Nguyen President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
675,000
+41.48%
|
-
|
|
Jan 08
2024
|
Pascal Touchon President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
1,280,000
+39.81%
|
-
|